Exchange: NSE·Updated 10:05 AM GMT+5:30

SYNGENE.NSE News

News
all
press releases
Raja Venkatraman, MarketSmith recommend five stocks for 4 May
After a dip in late April, Indian markets may start positively on May 4, driven by a favourable Gift Nifty. Analysts recommend buying stocks such as Syngene International and DCM Shriram, highlighting their growth potential despite recent market volatility.
cityfalcon.com
More News
India-EU trade deal: OneSource Specialty, Syngene, Sigachi, other pharma stocks tank up to 19%; here's why
… lower input costs for Indian pharma companies sourcing specialised ingredients from … stocks. On BSE, OneSource Specialty Pharma (19%), Syngene International (11%), Sigachi … .41%), Wanbury Ltd (7%), Kwality Pharmaceuticals (5.67%), Supriya Lifescience (6% …
cityfalcon.com
GSK Pharma to Procure 4.95 MWp Solar Power from CleanMax in Maharashtra
GlaxoSmithKline Pharmaceuticals (GSK Pharma ) will procure 4.95 MWp … , Syngene International, a Bengaluru-based pharmaceutical company, announced procuring renewable energy … February 2025, Mumbai-based Aarti Drugs partnered with Prozeal Green Energy …
cityfalcon.com
India’s Healthcare Index Sinks After Trump’s Pharma Tariff Blow — SEBI Analyst Sees Risks For Gland, Biocon, Dr. Reddy’s
The analyst noted that Syngene, Piramal Pharma, and Zydus Lifesciences may be better positioned, as their contract manufacturing models and biologics portfolios are less susceptible to the tariff impact.
Stocktwits
Trading Radar For August 21: Vedanta, Zee Entertainment, Clean Science, India Cements, Railtel Are On Stocks Watchlist
Gem Aromatics, Patel Retail, Shreeji Shipping Global, Vikram Solar, and Mangal Electrical Industries IPOs are currently open for subscription
Stocktwits
Syngene International reports 11% revenue growth and 59% net profit surge in Q1
Syngene International, a Biocon subsidiary, reveals an 11% revenue increase to Rs 875 crore for the first quarter. Net profit jumps 59% to Rs 87 crore. Growth is attributed to research services and biologics manufacturing. Operations commenced at Unit III in Bengaluru. Preparations advance for the Bayview facility in the US.
cityfalcon.com
Syngene Consolidates Ahead Of Q1 Earnings: SEBI RA Rohit Mehta Sees Potential Breakout Above ₹700
While past earnings have been positive, the stock trades at a high valuation and offers a low dividend payout
Stocktwits
July Stock Themes: SEBI RA Rohit Mehta Flags Renewables, Pharma, Infra Sectors For Big Rotations
India's clean energy push, pharma transformation, and record capex plans are drawing investor focus heading into July, with key beneficiaries emerging across all three sectors.
Stocktwits
Syngene International shares in focus after positive USFDA updates for 2 Bengaluru facilities
Syngene International shares:The initial update concerns a Good Clinical Practices (GCP) compliance inspection carried out at Syngene’s Semicon Park facility in Bengaluru between June 9 and June 13, 2025. The inspection resulted in no findings, and no Form 483 was issued. It was classified as “No Action Indicated” (NAI), indicating full adherence to regulatory standards.
cityfalcon.com
India Market Wrap: Nifty, Sensex Snap 7-Day Gains, FMCG Stocks Drag
Benchmark indices ended their seven-day winning streak on Thursday, dragged by FMCG stocks and expiry-related volatility; however, pharma and real estate stocks provided some cushion.
Stocktwits

Advertisement|Remove ads.